Key Metrics
CiteScore 

39.2
Eigenfactor 

0.05 - 0.1
Impact Factor 

>= 25
Scite Index 

0.87 5-Year SI

SJR 

Q1Hepatology

SNIP 

6.27
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Hepatology
Journal of Hepatology Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1985 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Hepatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Hepatology
Reply to: "Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China".
- 12 May 2026
- Journal of hepatology
Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.
- 11 May 2026
- Journal of hepatology
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.
- 9 May 2026
- Journal of hepatology
Extracorporeal xenogeneic liver support: Defining the first clinical niche.
- 7 May 2026
- Journal of hepatology
A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma.
- 6 May 2026
- Journal of hepatology
Reply to Goldberg and Tapper Refining ACLF diagnosis: Beyond the scorecard.
- 5 May 2026
- Journal of hepatology
Reply to: "Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China".
- 12 May 2026
- Journal of hepatology
Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.
- 11 May 2026
- Journal of hepatology
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.
- 9 May 2026
- Journal of hepatology
Extracorporeal xenogeneic liver support: Defining the first clinical niche.
- 7 May 2026
- Journal of hepatology
A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma.
- 6 May 2026
- Journal of hepatology
Reply to Goldberg and Tapper Refining ACLF diagnosis: Beyond the scorecard.
- 5 May 2026
- Journal of hepatology